GUANGDONG,China,Sept. 16,2024-- Since the Tang Dynasty (618-907),Guangzhou in Guangdong Province has been a prominent port where Sino-foreign trade flourished,attracting numerous foreign merchants who
SoftwareSep 17, 2024In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs),ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an ov
BiologySep 17, 2024CAAS announces the conference call and webcast information for the Annual Meeting of Stockholders to be held on Tuesday,September 24,2024 at 9:00 AM local time,or 9:00 PM EDT on Monday,September 23,20
ScienceSep 17, 2024PORT VILA,Vanuatu,Sept. 16,2024-- Vantage Markets (or "Vantage"),a leading multi-asset broker,is excited to announce a major update to its copy trading platform,alongside the launch of anot
Big DataSep 17, 2024HONG KONG,Sept. 16,2024-- At the 2024 European Society for Medical Oncology (ESMO) Conference,Akeso (9926.HK) published the phase 2 results from its ivonescimab in combination with chemotherapy as a f
BiologySep 17, 2024RIYADH,Saudi Arabia,Sept. 16,2024--As the AFC Champions League EliteTM is officially kicking off,TECNO,the Official Global Supporter of AFC Club Competitions,is delighted to unveil its #GoalTogether
AISep 17, 2024STOCKHOLM,Sept. 16,2024-- Autoliv,Inc. (NYSE: ALV)(SSE: ALIVsdb),the worldwide leader in automotive safety systems,announces that it has added a new independent member to its Board of Directors effect
Chip TechSep 17, 2024SINGAPORE,Sept. 16,2024-- NEC APAC emerged as the winner for the Rising Star Award (Managed Cybersecurity Services category) through the voting of subscribers and readers of CybersecAsia.Net: CISOs,t
Big DataSep 17, 2024BERLIN,Sept. 16,2024-- Market Logic Software,a global leader in insights management solutions,is excited to announce the latest release of the award-winning DeepSights™,its powerful AI-driven insigh
TechSep 17, 2024SUZHOU,China,Sept. 16,2024--Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 were presente
Chip TechSep 17, 2024
Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.
© ArinstarTechnology
Privacy Policy